Genome sequencing studies have identified recurring founder mutations within the substrate-binding cleft of speckle-type POZ protein (SPOP), a cullin-RING ubiquitin ligase adaptor, in about 10% of primary prostate cancers [20]. Here, SPOP is linked to prostate cancer.